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Summary 
We compared T cell receptor (TCK) V-segment frequencies in human leukocyte antigen (HLA) 
identical siblings to sibling pairs who differ at one or both HLA haplotypes using four Vfl- 
specific and one Vot-specific monoclonal antibody. In every one of nine families HLA-identical 
sibs had the most similar patterns of V-segment frequencies in their peripheral blood, whereas 
totally mismatched sihs were, in general, the most dissimilar; HLA haploidentical sibs tended 
to be intermediate between the two groups. The degree of similarity among HLA-identical fibs 
was comparable to that observed among three pairs of identical twins suggesting that HLA is 
the major  genetic component influencing TCK V-segment frequency. Consistent  with  this 
observation, it was found that the frequency of T ceils expressing particular Vfl segments was 
skewed towards either CD4 + or CD8 + cells indicating that T cells expressing some Vfl genes 
may be positively selected primarily by class I or class II major histocompatibility complex proteins. 
Finally,  it was observed that individuals who express the HLA class I specificity,  B38, tend to 
express high levels of Vcz2.3 + cells among their CD8 § T  cells.  These observations represent 
definitive proof that human V-segment frequencies are profoundly influenced by the HLA complex. 
I 
n mice, the H-2 complex plays a prominent role in deter- 
mining TCR V-segment frequencies. Both class I and class 
II antigens influence the pattern of V-segment frequencies. 
This  occurs  either  by  negative  sdection  (1-5)  where 
CD4 +  8 + thymocytes expressing TCK with high affinity for 
self MHC molecules plus endogenous peptide are clonaUy 
deleted or, by positive selection (6-13) where thymocytes  with 
TCR expressing low affinity for the complex are permitted 
to mature into T cells capable of recognizing "foreign" pep- 
tides presented by self MHC molecules. A similar effect on 
human V-segment frequencies by the HLA complex has been 
difficult to demonstrate presumably because of the genetic 
heterogeneity and complexity of the HLA region in the out- 
bred human population. In order to circumvent these difficul- 
ties we have analyzed V-segment frequencies within nine large 
families consisting of multiple siblings.  In particular we have 
compared the V-segment frequency patterns of HLA-identical 
siblings to sibling pairs who differ at one or both HLA haplo- 
types. This experimental approach has allowed us to demon- 
strate the influence of HLA genes on V-segment frequencies 
in human peripheral blood T  cells. 
Materials and Methods 
Cell Preparation.  Peripheral  blood was obtained from normal 
volunteers. Mononuclear cells were isolated  by Ficoll/Hypaque gra- 
dient separation and T cells were isolated using magnetic beads 
to which anti-CD2 mAb was covalently  coupled (Dynal Inc., Great 
Neck, NY). After overnight incubation, the spontaneously  released 
cells were separated into CD4 + and CD8 + cells using magnetic 
beads  covalently coupled  with  anti-CD4  and  anti-CD8.  The 
CD4 + and CDS+ cells obtained were >98% pure. Cold blood 
cells were purified by FicoU/Hypaque centrifugation and, after lysis 
of red blood cells by incubation in Tris-ammonium chloride for 
5 min at 37~  were used directly for analysis. 
Monoclonal Antibodies.  The TCR mAbs $511, C37, OT145, 
16G8, and F1 have been described earlier (14-20) and are directed 
against Vf112 (15), Vfl5.2/5.3  (reference 16, and our unpublished 
data), VB6.7a (18), VB8.1/8.2 (19) and V~ 2.3 (reference 20, our 
unpublished data), respectively.  The negative  control antibodies were 
an anti-IgM private idiotype antibody (IgG2a), and an anti-dini- 
trophenol antibody (IgG1). A positive control antibody, anti-CD3 
(IgG2a), was also used. 
Immunofluorescent Analysis.  Peripheral  blood lymphocytes were 
analyzed  by  indirect  immunofluorescence.  Purified  CD4 §  or 
CD8 + cells (5  x  10  s) were incubated with 10 #1 of 1:100 diluted 
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% of T  cells reacting with 
$511  C37  OT145  16G8  F1 
Family and 
HLA haplotype  CD4  CD8  CD4  CD8  CD4  CD8  CD4  CD8  CD4  CD8 
Swi 
GS: b/c  2.3  1.8  2.7  3.2  3.1  1.4  4.0  4.3  2.9  3.5 
LS: b/c  3.3  1.7  3.6  3.3  3.5  1.4  4.9  3.4  3.3  3.3 
PS:  b/c  2.3  1.2  3.1  2.8  3.5  1.1  3.8  3.6  3.2  2.9 
MS: b/c  3.2  1.2  2.0  1.9  2.5  1.2  4.0  3.9  3.4  4.3 
ES: b/d  5.0  1.7  3.2  3.8  5.3  2.2  6.9  4.2  5.3  4.6 
Dou 
KD:  a/c  1.4  1.9  2.2  2.4  2.2  1.2  2.5  2.8  3.8  3.1 
TD:  a/c  1.4  1.6  2.1  2.3  1.9  1.1  2.6  2.0  3.1  3.0 
ED: b/d  1.7  4.8  2.6  4.4  4.0  1.8  4.3  5.3  3.5  4.9 
SD: b/c  1.3  1.1  2.6  2.0  0.3  0.3  3.2  2.4  3.2  2.9 
Com 
MC:a/c  3.5  1.7  3.4  3.1  3.4  1.7  5.2  4.2  3.8  1.9 
LC:  a/c  3.2  1.4  2.8  3.3  4.8  1.5  4.8  4.2  4.9  2.7 
DC:  a/d  2.3  2.2  1.8  3.2  3.1  2.4  3.6  4.8  3.1  2.9 
PC:  a/d  3.0  1.5  2.6  2.4  3.3  3.3  3.6  5.3  3.9  2.0 
MiC:  a/d  2.2  1.5  2.7  3.0  3.3  1.6  3.1  4.5  2.9  2.0 
LaC: b/d  1.5  0.8  2.0  2.0  1.9  1.0  2.4  2.9  2.5  1.9 
Mey 
HM:  a/d  1.5  0.9  2.6  2.8  7.5  2.0  3.3  3.1  2.8  3.8 
TM:  a/d  1.7  1.0  3.2  2.9  6.8  2.2  2.7  2.5  2.6  3.8 
CM:  a/c  1.5  0.6  2.7  1.9  5.4  2.3  1.7  3.6  3.3  4.3 
DM:  b/c  1.4  1.3  2.8  2.1  3.8  1.2  1.9  2.0  2.7  3.6 
Man-2 
AM: a/c  2.5  1.2  1.8  3.3  3.3  1.4  3.3  4.4  3.3  2.3 
MoM:  a/c  2.6  1.1  2.4  3.1  3.5  1.6  4.1  3.1  2.8  2.8 
BM:  b/d  4.2  1.1  2.7  3.1  4.8  1.4  4.9  3.6  4.2  2.6 
MiM:  b/d  4.9  1.1  3.9  3.5  4.0  1.8  4.4  4.3  5.3  2.8 
MaM"  a/d  5.5  1.4  3.4  2.5  4.5  0.8  6.6  4.2  5.0  3.3 
Man 
AM(f): a/b  1.8  2.3  2.3  3.6  1.3  1.0  2.8  2.7  2.8  3.7 
KM(m): c/d  2.2  1.2  1.3  3.5  2.1  1.3  2.8  3.0  1.6  3.0 
AIM:  a/c  2.0  1.4  1.6  3.3  1.1  0.9  2.5  3.0  2.7  3.0 
SM: a/c  1.9  1.4  1.9  3.5  1.4  0.9  2.2  2.9  2.8  3.6 
SiM: b/c  2.6  1.5  2.2  3.1  0.5  0.3  2.8  2.2  2.5  3.3 
Manj 
SM(f):  a/b  1.2  1.0  0.4  1.4  0.8  0.5  3.2  7.5  2.6  2.4 
LM(m): c/d  0.3  0.9  1.6  3.6  2.0  0.3  4.8  3.4  5.1  4.5 
RM:  a/c  1.2  1.3  0.5  0.2  1.0  0.2  4.3  3.1  2.8  1.9 
AM: a/c  1.3  1.5  0.4  0.6  1.4  0.4  3.5  2.9  2.9  2.2 
continued 
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% of T cells reacting with 
$511  C37  OT145  16G8  F1 
Family and 
HLA haplotype  CD4  CD8  CD4  CD8  CD4  CD8  CD4  CD8  CD4  CD8 
Kle 
FK(f):  a/b  1.9  2.4  1.8  3.9  3.0  3.0  3.7  5.7  5.1  4.8 
AK(m): c/d  2.9  2.8  2.6  4.7  4.2  2.9  3.2  3.9  3.7  3.2 
KK: a/d  1.2  0.7  1.9  3.8  6.3  2.7  2.4  2.9  3.3  3.6 
SK: a/d  1.3  1.0  1.6  2.5  3.6  1.7  2.1  2.4  3.7  3.0 
TK: a/c  1.6  1.1  2.6  1.3  0.9  0.8  2.6  2.9  3.3  3.8 
AK: b/d  2.4  1.0  2.4  11.4  2.4  1.2  2.2  2.3  2.8  2.5 
Pla 
SP(f): a/b  2.1  2.0  2.1  2.7  3.4  1.7  3.7  2.5  3.0  4.0 
CP(m): c/d  1.8  1.8  2.0  2.0  3.8  2.1  3.3  3.2  2.3  6.1 
DP" a/c  1.9  1.2  1.9  1.8  3.0  1.5  3.3  3.3  2.4  4.6 
SP: a/c  1.5  1.1  1.6  1.8  3.1  1.4  3.3  2.7  1.7  4.7 
Identical Twins 
Mur 
DM  3.3  0.7  2.6  2.8  3.3  1.2  4.3  3.4  4.5  3.1 
KM  4.0  1.5  3.4  2.4  3.4  1.4  5.7  2.9  4.6  2.6 
Co 
MC  1.6  1.1  2.4  4.3  2.1  2.0  2.2  1.7  3.1  2.1 
DC  1.0  0.8  2.1  3.9  2.0  2.1  2.5  1.5  2.7  2.4 
Lac 
CL  0.0  3.1  2.8  3.1  2.4  1.4  3.1  5.1  1,9  2.4 
JL  0.0  1.6  2.4  2.8  2.4  1.4  4.0  4.2  2.1  2.3 
All individuals listed represent siblings except those indicated by "f" (father) and "m" (mother). 
ascites for 45 rain at room temperature, washed 3 times with PBS 
containing 1% BSA and 0.02% sodium azide and further incubated 
for 30 min at room temperature with fluoresceinated  goat F(ab')~ 
anti-mouse IgG antibody (Organon Technika-Cappel, Durham, 
NC). The cells were washed in PBS and fixed with 2.8% formal- 
dehyde. For cytofluorographic analysis, forward and 90  ~ scatter 
parameters were selected to include only lymphocytes in the anal- 
ysis. The region selected for counting was adjusted to yield nega- 
tive control values of less than 0.1%. The negative control values 
were subtracted from the percentage of cells staining with a given 
test antibody and the number was expressed as a percentage  of total 
T cells. The percent T cells was routinely >90% based on staining 
with the anti-CD3  MAb. Purified cord blood cells were ana- 
lyzed by direct immunofluorescence, using FITC-labeled T cell 
receptor antibodies (T Cell Sciences Inc., Cambridge, MA) and 
phycoerythrin-labeled  CD4 and CD8 antibodies (Becton-Dickinson 
and Co., Mountain View, CA). Cells (5  x  10  s) were incubated 
sequentially with 10/zl of FITC-labeled and PE-labeled antibody 
at 4~  for 30 min, washed 3 times and analyzed  by flow cytometry. 
HLA Typing.  HLA typing for class I and class II antigens was 
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performed by conventional  microcytotoxicity  using alloantisera  and 
several selected mAbs directed against DQ and DR specificities. 
The HLA types for the nine families and three pairs of identical 
twins listed in Table 1 and Fig. 1 are: Swi:A2, B12, DK2, DQwl 
(haplotype a); A2, B5, DR5, DQw3 (haplotype b); Aw34, B17, 
DR2, DQwl (haplotype c); A23(9), B17, DKw6, DQwl (haplo- 
type d); Dou:A2, B44(12), DR7, DQw3 (a); A1, B8, DtL3, DQw2 
(b); A26(10), Bw57(17), DR7, DQw2 (c); A3, Bw55(w22), DR2, 
DQwl (d); Corn:A2, B7, DR2, DQwl (a); All, B7, DR1, DQwl 
(b); A25(10), B39, DR7, DQw2 (c); A3, Bw60(40), DR4, DQw7 
(d); Mey:A2, B39(16), DR1, DQwl (a); Aw33, Bw58(17), DtL3, 
DQw2 (b); A3, B35, DIL2, DQwl (c); All, B51(5), DR1, DQwl 
(d); Man-2:A11, Bw52(5), DRw11, DQw7 (a); A1, Bw60(40), 
DtL3, DQw2 (b); Aw33(w19), B17, DRw13, DQwl (c); A24(9), 
Bw52, DR7, DQw2 (d); Man:A24(9), B8, DR.3, DQw2 (a); A1, 
DK2, DQwl (b); All, B35, DK2, DQwl (c); Bw62(15), DR.5, 
DQw3 (d); M~mj:A26(10), B8, Dt~, DQw2 (a); Aw33(w19), 
B44(12), DR7, DQw2 (b); A32(w19), Bw52(5), DR7, DQw2 (c); 
A24(9), Bw57(17), DI~, DQw2 (d); Kle:A29(w19), B44(12), 
DR7, DQw2 (a); Aw33(w19), B14, DRw13, DQwl (b); A31(w19), 20 
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Figure  1.  Pairwise comparisons of 
V-segraent frequency  patterns of HLA- 
identical (Q), one haplotype-identical 
(Q), and zero haplotype-identical (O) 
individuals of the same family. A values 
were  computed by  pairwise  comparisons 
between  individuals within  families, 
listed  in Table I, of the frequencies  of 
CD4 + and CD8 + T cells  reactive  with 
each of the mAb  used in this  study. 
B51(5), DILw11, DQw7 (c); All, B18, DR3, DQw2 (d); Pla:A3, 
B38(16), DIL4, DQw3 (a); A1, B17, DRw13, DQwl (b); A30, 
B38(16), DRw13,  DQwl  (c); All,  B51(5), DR4,  DQw7 (d); 
Mur:A2,3, Bw60(40), 44(12), DR3, 4, DQw2, w7; Co:All, B13, 
w60(40),  DR2,  DQwl;  Lac:A2,26(10),  B37,w41, DR3,w13, 
DQwl,w2. 
The HLA-B38 individuals shown in Fig. 3 were derived from 
the Pla family (listed above), the Sie family, and three unrelated 
normal donors. The HLA typing for the 3 members of the Sie 
family are: A26(10), B38(16), DR4 (a haplotype) and Aw34(10), 
B38(16), DR4 (b haplotype) for the father; A26(10), B38(16), DR4 
(a haplotype) and Aw34(10), B35, DR4 (d haplotype) for the son; 
Aw34(10), B35, DR4 (d haplotype) and Aw34(10), B38(16), DR4 
(b haplotype) for the daughter. Note that HLA-B38 is carried on 
both the a and b haplotypes in the Sie family. The 3 unrelated 
B38 + individuals were: A.H.; A1, A26(10); B44(12),38(16); DR.4, 
w13; B.T.; A24(9); B44(12),38(16); DR4, wD;J.S.; A1,8; B38(16), 
18; DR2,3. 
Results  and  Discussion 
To determine whether HLA plays a significant role in de- 
termining  TCR  V-segment  frequencies  we  analyzed  the 
members of nine large families in which we could identify 
HLA-identical sibs as well as sibling pairs who differed at 
one or both HLA haplotypes. We reasoned that if HLA was 
important in determining V-segment frequencies, we should 
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Figure 2.  The ratio of the percentage 
of CD4/CD8 T cells reactive with each 
of the mAb for all of the individuals 
in the study. Peripheral blood T cells 
and cord blood cells were analyzed as, 
described in Materials and Methods. 
find that  HLA-identical sibs have more similar V-segment 
frequencies than sibling pairs who differ at one or both HLA 
haplotypes. This sort of analysis is similar to that which was 
employed to demonstrate that HLA antigens play a role in 
organ and tissue transplants,  namely that transplants between 
HLA identical sibs have a lower frequency of rejection than 
those between haplo-identical  sibs.  To measure V-segment 
1143  Gulwani-Akolkar et al. 
frequencies, a pand of five MAbs directed against V312 ($511), 
V35.2/5.3 (C37), V36.7a (OT145), V38.1/8.2 (16G8) and 
Vot 2.3 (F1)  was used. 
We  found  that  the  average  percent  of CD4 +  T  cells 
reacting with the five individual mAbs was 2.10  _+ 1.01 (mean 
__  SD) ($511),  2.16  +  0.80 (C37)  2.84  _+  1.50 (OT145), 
3.46  _+  1.08 (16G8), and 3.11  __ 0.86 (F1). The average per- B.O  ￿9 
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Figure  3.  Frequency  of  CD4 ~  and  CD8 +  T  cells  expressing  F1 
(Vo~2.3) in B38 and non-B38 individuals. The ten indi~duats expressing 
B38 represent  six different B38 haplotypes (see Materials and Methods) 
and include the four members of the "Pla" family (Table 1), three members 
of the "Sie" kmily  (father and two children), and three unrelated individuals. 
cent of CD8 + T  cells reacting with the individual MAbs 
was 1.55  +-  0.82 ($511), 2.89  _  1.45 (C37),  1.50  _  0.69 
(OT145), 3.53  _  1.12 (16G8) and 3.41  ___ 1.16 (F1). For each 
antibody there was wide variation in reactivity among the 
67 individuals in this study as shown in Table 1 and as indi- 
cated by the standard deviation. 
Similarities in V-segment frequency patterns were deter- 
mined by comparing the frequency of T cells reacting with 
the five V  region-specific mAbs  in  both  the CD4 +  and 
CD8 + populations. Thus, 10 parameters were used to assess 
the V-segment frequency pattern of each individual. Similar- 
ities and differences between two-paired siblings (or in some 
cases parent and child) were calculated by adding the differ- 
ences for each parameter. Thus, the sum (A score) of the ab- 
solute differences for all ten parameters in each pairwise com- 
parison  represents  the degree of differences between two 
individuals,  and is displayed in Fig.  1. 
We found that in every family, HLA-identical sibs had the 
most similar V-segment frequency patterns as indicated by 
the lowest A  scores in Fig.  L  whereas totally mismatched 
sibs were, in general, the most dissimilar in their V-segment 
frequency patterns;  HLA haplo-identical sibs tended to be 
intermediate between the two groups (Fig.  1). The differ- 
ences in A scores between HLA-identical sibs and those that 
differed at one or both  HLA haplotypes was statistically 
significant as determined by a two-way analysis of variance 
(F <  0.001).  Furthermore, the degree of similarity among 
HLA-identical silos was, in most instances, comparable to the 
degree of similarity observed among three pairs of identical 
twins, suggesting that HLA is the major genetic component 
that influences V-segment frequencies. It is intriguing to note 
that in some families the A values for HLA-nonidentical pairs 
were very high, as seen in the family, "Kle'" while in other 
families  such  as  "Man"  and  "Pla",  A  values  were closely 
clustered within a low range of values. This may be clue to 
the differing effects of disparate  HLA  haplotypes  on the 
V-segment frequencies as defined by the mAb used. Alterna- 
tively, it is possible that polymorphic genetic loci other than 
HLA  (such as  endogenous superantigens)  are influencing 
V-segment frequencies or,  that  nongenetic environmental 
influences such as antigen exposure may skew V-segment fre- 
quencies  significantly.  However,  the close correlation be- 
tween the degree of sharing of HLA haplotypes and A values 
strongly suggests that the observed V-segment frequency pat- 
tern is predominantly influenced by HLA genes. An alterna- 
tive possibility is that another gene(s) located within the HLA 
complex is influencing the frequency pattern. This is highly 
unlikely since it would require that this gene(s) display a de- 
gree of polymorphism comparable to the classical HLA dass 
I and class II genes. 
It was also observed that  the frequency of some T  cell 
receptor V  segments was skewed towards either CD4 + or 
CD8 + cells. This is apparent it~ Fig. 2 (bottom) where the 
ratio  of percentages of CD4*/CD8 +  cells  reacting with 
each antibody is plotted for all the individuals analyzed. A 
statistical  comparison of the five  mAbs  using  a  repeated 
measures analysis of variance demonstrated that the CD4/CD8 
ratios for $511, C37, and OT145 differed significantly from 
16G8 and F1,  whose average ratios were one (p <  0.005). 
The ratio of percentages of $511"  T cells in the CD4/CD8 
populations was 1.58  _+  0.93 and the ratio for OT145 + T 
cells was 2.06  +  1.09, demonstrating a bias towards expres- 
sion  of CD4 ~  T  cells.  In  contrast,  C37  reacted with  a 
higher percentage in the CD8 ~ population (CD4*/CD8 + 
ratio of 0.85  -_- 0.38). When cord blood was examined, we 
observed a similar skewing (Fig. 2, top) indicating that naive 
T cells lacking a history of antigenic exposure have the same 
bias in V-segment frequency in CD4 + and CD8 § T  cells. 
A comparable skewing has also been observed in a Scandina- 
vian population (21). The observed skewing of V-segment 
frequencies in either CDS*  or CD4 + T  cells is consistent 
with an effect of HLA class I and class II antigens, respec- 
tively,  on positive selection of T  cells expressing particular 
V3 segments. 
Finally,  we have observed an association between HLA- 
B38 and V~2.3 frequency in CD8 + T  cells.  As shown in 
Fig. 3, the frequency of V0~2.3" T ceils in the CD8 + popu- 
lation equals or exceeds 4% in the ten individuals who carry 
HLA-B38, with an average frequency of 5.2%  __.  1.2. This 
contrasts with an average frequency of 3.1%  _+  .84 in non- 
B38 individuals.  Indeed, the four individuals with the highest 
values of Vc~2.3 § T cells in the CD8 population (5.5-7.5%) 
all carry the B38 allele. A t test indicates that this difference 
1144  T  Cell Receptor V-Segment Frequencies  in Peripheral  Blood T  Cells between  B38 +  and  B38-  individuals  is  statistically 
significant (p < 0.0001). No significant difference in the fre- 
quency of Voe2.3 + T  cells is seen between B38 + and B38- 
individuals in the CD4 + population. It should be noted that 
the HLA-B38 allele is frequently located on a particular ex- 
tended haplotype, A26 B38 DR4(Dwl0), which is found pre- 
dominantly in the Askenazi Jewish population (22). Indeed, 
nine of the ten B38 individuals are also DR4. However, the 
enrichment for Voe2.3 +  T  cells  specifically  in  the  CD8 + 
population suggests that a class I allele such as B38 is respon- 
sible for this effect and is consistent with previous observa- 
tions in the mouse on positive selection by dass I alleles (4, 
10,  11). Further studies on additional B38 + ,DR4-  families 
to determine whether HLA-B38 segregates with high levels 
of Vot2.3 + T  cells in the CD8 population independent of 
DR4 are necessary to confirm this intriguing observation. 
Finally, it is of interest that the A26 B38 DR4 haplotype 
has been specifically associated  with susceptibility to an au- 
toimmune disease,  pemphigus vulgaris (23). Susceptibility 
to psoriatic arthritis has also been associated with HLA-B38 
(24). The current findings raise the possibility that these HLA 
associations with disease may be due to the effects of HLA 
antigens in determining TCR V-segment frequencies, thereby 
biasing the individual toward the development of autoim- 
munity. 
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